Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis-Claude Roy

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Transplantation and Cellular Therapy|October 6, 2020
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe InfectionsMaude Dumont-Lagacé, Qi Li, Mégane Tanguay, et al.
Bone Marrow Transplantation|January 17, 2018
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Bone Marrow Transplantation|September 21, 2018
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Blood|August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemiasChristopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
The Lancet. Haematology|November 10, 2019
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility studySandra Cohen, Jean Roy, Silvy Lachance, et al.
Bone Marrow Transplantation|March 6, 2019
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Open Forum Infectious Diseases|January 30, 2026
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative DisordersLorne Schweitzer, Stéphanie Thiant, Cynthia Thérien, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Transplantation and Cellular Therapy|October 6, 2020
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe InfectionsMaude Dumont-Lagacé, Qi Li, Mégane Tanguay, et al.
Bone Marrow Transplantation|January 17, 2018
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Bone Marrow Transplantation|September 21, 2018
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Blood|August 24, 2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemiasChristopher J Walker, Joshua J Oaks, Ramasamy Santhanam, et al.
The Lancet. Haematology|November 10, 2019
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility studySandra Cohen, Jean Roy, Silvy Lachance, et al.
Bone Marrow Transplantation|March 6, 2019
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Open Forum Infectious Diseases|January 30, 2026
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative DisordersLorne Schweitzer, Stéphanie Thiant, Cynthia Thérien, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
The Journal of Clinical Investigation|September 4, 2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cellsPaolo Neviani, Jason G Harb, Joshua J Oaks, et al.
Pageof 8